Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-02-27
Completion Date
2027-10-01
Last Updated
2025-10-03
Healthy Volunteers
No
Conditions
Interventions
Tensi+
Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management.
Locations (17)
HFME - Hospices Civils de Lyon
Bron, France
CHU de Rennes
Rennes, France
CHU de Rennes
Rennes, France
CHU de Rouen - Hôpital Charles Nicolle
Rouen, France
Nuova Villa Esther
Avellino, Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Hesperia Hospital
Modena, Italy
Santa Maria la Gruccia Hospital
Montevarchi, Italy
Policlinico Tor Vergata
Roma, Italy
Casa di Cura Villa Stuart
Roma, Italy
Villa Salaria Hospital
Roma, Italy
Azienda Ospedaliero Universitaria Sant'Andrea
Roma, Italy
Azienda Ospedaliero Universitaria Sant'Andrea
Roma, Italy
Clinica Nuova Villa Claudia
Roma, Italy
Bristol Urological Institute
Bristol, United Kingdom
Addenbrooke's Hospital, Cambridge University Hospital Trust
Cambridge, United Kingdom
University College Hospital London
London, United Kingdom